Company intelligence / Profile preview

Shangkang Life Science

Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Shangkang Life Science, formed as a joint venture between Shineco and Yangzhou Kangling Medical, develops and commercializes specialized medical devices for geriatric and chronic-care applications, including electro-acupuncture devices capable of biomolecule delivery and AI-integrated biosensor platforms for real-time elderly health monitoring. No clinical trial data typical of drug development; products appear approved for sale at the device level in China.

Therapeutic areas: RheumatologyOther
Modalities: DeviceBiologic
Industry: Physiological Monitoring

Partnerships

Yangzhou Kangling MedicalTuring Video

Beyond the preview

Go deeper on Shangkang Life Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shangkang Life Science.

Explore the full profile